Blue Cross and Blue Shield of North Carolina Expands Specialty Pharmacy Precertification List (Healthy Blue + Medicare (HMO D-SNP))
April 29, 2024
Please note, this communication applies to Healthy Blue + Medicare℠ (HMO-POS D-SNP) offered by Blue Cross and Blue Shield of North Carolina.
Effective for dates of service on and after August 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.
Federal and state law, as well as state contract language and CMS guidelines – including definitions and specific contract provisions / exclusions – take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.
| HCPCS or CPT® codes | Medicare Part B drugs |
| J9286 | Columvi (glofitamab-gxbm) |
| C9162, J3490, J3590, J9999 | Izervay (avacincaptad pegol) |
| J9333 | Rystiggo (rozanolixizumab-noli) |
| J9334 | Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc) |
We look forward to working together to achieve improved outcomes.